Medicare negotiations for lower drug prices near the finish lineMedicare can now negotiate drug prices, benefiting seniors by potentially lowering costs for high-cost medications.
Big Pharma is losing its fight to avoid prescription drug price negotiationsThe federal court rejected AstraZeneca's claim on prescription drug price negotiations under the 2022 IRA.The ruling impacts 10 Medicare Part D-covered prescriptions and aims to set fair prices for these drugs.